BII
KITE

Bainco International Investors’s Kite Pharma, Inc. KITE Stock Holding History

Bainco International Investors’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-27,840
Closed -$2.89M – 93
2017
Q2 		$2.89M Sell
27,840
-852,000
-97% -$69.5M 0.43% 57
2017
Q1 		$69.1M Sell
879,840
-271,700
-24% -$16.8M 9.77% 1
2016
Q4 		$51.6M Buy
1,151,540
+480,000
+71% +$23.5M 8.77% 1
2016
Q3 		$37.5M Buy
671,540
+647,750
+2,723% +$36.1M 6.85% 1
2016
Q2 		$1.19M Buy
23,790
+19,010
+398% +$934K 0.26% 59
2016
Q1 		$219K Buy
4,780
+1,010
+27% +$48.9K 0.05% 73
2015
Q4 		$232K Buy
+3,770
New +$265K 0.05% 72

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bainco International Investors's KITE Position: Q3 2017 in Review

Bainco International Investors sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 27,840 shares — an estimated $2.89M sold.

Bainco International Investors first reported a position in KITE in Q4 2015 and held it in 7 quarters. The position peaked at $69.1M in Q1 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Bainco International Investors reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Bainco International Investors sold 27,840 Kite Pharma, Inc. shares in Q3 2017, an estimated $2.89M.
  • Bainco International Investors first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 7 quarters.
  • Bainco International Investors's Kite Pharma, Inc. position peaked at $69.1M in Q1 2017.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Bainco International Investors's 13F filing for Q3 2017, filed 27 Oct 2017.